Effect of glycosylated hemoglobin on response to ranibizumab therapy in diabetic macular edema: real-world outcomes in 312 patients.

CONCLUSIONS: HbA1c is not related to functional or anatomical outcomes at 1 year in DME treated with ranibizumab.
PMID: 30119798 [PubMed - in process]

Source: Canadian Journal of Ophthalmology - August 1, 2018 Category: Opthalmology Authors: Shalchi Z, Okada M, Bruynseels A, Palethorpe D, Yusuf A, Hussain R, Herrspiegel C, Scazzarriello A, Habib A, Amin R, Rajendram R Tags: Can J Ophthalmol Source Type: research